All Stories

  1. Lateral orbitofrontal cortex enables new learning to overwrite previously acquired information
  2. Early Hippocampal Stress Responses to Short-Term Cigarette Smoke Exposure in Mice
  3. Contingency degradation overwrites initial learning and depends on lateral orbitofrontal cortex
  4. The Hidden Anatomy of Low Back Pain: Uncovering the Impact of Mamillo-Accessory Ligament Ossification
  5. Contingency Degradation Overwrites Initial Learning and Depends on Lateral Orbitofrontal Cortex
  6. Integrating clinical scenarios in undergraduate anatomy teaching to enhance student engagement: A three‐year exploratory study in a small pre‐medicine cohort
  7. Correction: Thomas Broome, S.; Castorina, A. Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice. Biomedicines 2022, 10, 3174
  8. PAC1 Receptor Knockout Mice Reveal Critical Links Between ER Stress, Myelin Homeostasis, and Neurodegeneration
  9. Optimum heat reflux extraction of key bioactive compounds from lemon scented tea tree ( Leptospermum petersonii) leaves and their cytotoxic effects
  10. A Standard Operating Procedure for Dual-Task Training to Improve Physical and Cognitive Function in Older Adults: A Scoping Review
  11. VPAC1 and VPAC2 Receptor Heterozygosity Confers Distinct Biological Properties to BV2 Microglial Cells
  12. Increased Expression of the Neuropeptides PACAP/VIP in the Brain of Mice with CNS Targeted Production of IL-6 Is Mediated in Part by Trans-Signalling
  13. Differential Expression of PACAP/VIP Receptors in the Post-Mortem CNS White Matter of Multiple Sclerosis Donors
  14. Understanding Body Types and Physical Fitness in Young Professional Soccer Players
  15. Targeting the PAC1 receptor mitigates degradation of myelin and synaptic markers and diminishes locomotor deficits in the cuprizone demyelination model
  16. Small Extracellular Vesicle-Derived Circular RNA hsa_circ_0007386 as a Biomarker for the Diagnosis of Pleural Mesothelioma
  17. Adapted Physical Activity Programs for Children with Autism Spectrum Disorder and Neurotypical Children: Differences between Online and Face-to-Face Training
  18. Hippocampal neuroinflammation causes sex-specific disruptions in instrumental conditioning, Pavlovian approach, and neuronal excitation
  19. The Neuroanatomy of the Habenular Complex and Its Role in the Regulation of Affective Behaviors
  20. Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
  21. An Overview of Physical Exercise Program Protocols and Effects on the Physical Function in Multiple Sclerosis: An Umbrella Review
  22. Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
  23. Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
  24. L-Proline Prevents Endoplasmic Reticulum Stress in Microglial Cells Exposed to L-azetidine-2-carboxylic Acid
  25. Identification of Key Genes and Regulatory Pathways in Multiple Sclerosis Brain Samples: A Meta-Analysis of Micro-Array Datasets
  26. Molecular Assessment of Healthy Pathological Articular Cartilages in Physically Active People: A Scoping Review
  27. Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice
  28. Pro-Inflammatory and Pro-Apoptotic Effects of the Non-Protein Amino Acid L-Azetidine-2-Carboxylic Acid in BV2 Microglial Cells
  29. Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington’s Disease
  30. Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
  31. PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
  32. The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
  33. Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury
  34. Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet
  35. The role of exercise on peripheral nerve regeneration: from animal model to clinical application
  36. PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
  37. PACAP and VIP Modulate LPS-induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
  38. Doxycycline and Minocycline Act as Positive Allosteric Modulators of the PAC1 Receptor and Induce Plasminogen Activators in RT4 Schwann Cells
  39. Doxycycline and Minocycline act as Positive Allosteric Modulators of the PAC1 Receptor and Induce Plasminogen Activators in RT4 Schwann Cells
  40. Neuroprotective Effects of Physical Activity via the Adaptation of Astrocytes
  41. Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells
  42. Brain CHID1 Expression Correlates with NRGN and CALB1 in Healthy Subjects and AD Patients
  43. Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson’s Disease
  44. Evaluation of a Cell-Free Collagen Type I-Based Scaffold for Articular Cartilage Regeneration in an Orthotopic Rat Model
  45. Dopamine: an immune transmitter
  46. Moderate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key
  47. A correlation between intestinal microbiota dysbiosis and osteoarthritis
  48. Dopaminergic-GABAergic interplay and alcohol binge drinking
  49. PACAP and VIP expression in the periaqueductal grey of the rat following sciatic nerve constriction injury
  50. Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
  51. Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
  52. The “Journal of Functional Morphology and Kinesiology” Journal Club Series: Highlights on Recent Papers in Musculoskeletal Disorders
  53. Angiogenesis correlates with macrophage and mast cell infiltration in lung tissue of animals exposed to fluoro-edenite fibers
  54. Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution
  55. Enhanced expression of CD31/platelet endothelial cell adhesion molecule 1 (PECAM1) correlates with hypoxia inducible factor-1 alpha (HIF-1α) in human glioblastoma multiforme
  56. Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam
  57. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme
  58. Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
  59. PACAP Interacts with PAC1 Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures
  60. The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer′s disease: agonists or antagonists?
  61. Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?
  62. Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications
  63. Aluminum alters cellular defense response to amyloid beta in neuronal cells
  64. Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate
  65. Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone
  66. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: Involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways
  67. Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death
  68. Increased Hippocampal CREB Phosphorylation in Dopamine D3 Receptor Knockout Mice Following Passive Avoidance Conditioning
  69. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus
  70. Antiproliferative Effects of PACAP and VIP in Serum-Starved Glioma Cells
  71. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction
  72. Hippocampal Neurofibromin and Amyloid Precursor Protein Expression in Dopamine D3 Receptor Knock-out Mice Following Passive Avoidance Conditioning
  73. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats
  74. Involvement of PACAP/ADNP Signaling in the Resistance to Cell Death in Malignant Peripheral Nerve Sheath Tumor (MPNST) Cells
  75. Dopamine-3 receptor modulates intraocular pressure: Implications for glaucoma
  76. Epidermal growth factor receptor (EGFR) and neuregulin (Neu) activation in human airway epithelial cells exposed to nickel acetate
  77. Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death
  78. Neurofibromin and Amyloid Precursor Protein Expression in Dopamine D3 Receptor Knock-Out Mice Brains
  79. Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells
  80. PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells
  81. Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of ß-amyloid toxicity
  82. PACAP and VIP prevent apoptosis in schwannoma cells
  83. Parkin Expression Profile in Dopamine D3 Receptor Knock-Out Mice Brains
  84. Expression profile of ErbB receptor’s family in human alveolar type 2-like cell line A549 exposed to hexavalent chromium